cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction.

BACKGROUND Marked alterations in the expression of specific genes occur during the development of cardiac hypertrophy in vivo. Little is known, however, about the cis-acting elements that mediate these changes in response to clinically relevant hypertrophic stimuli, such as hemodynamic overload, in intact adult animals. METHODS AND RESULTS The left ventricular expression of a directly injected reporter gene driven by 3542 bp of rat beta-myosin heavy chain (beta-MHC) promoter was increased 3.0-fold by aortic constriction (P<.005), an increment similar to the 3.2-fold increase in the level of the endogenous beta-MHC mRNA in the same left ventricles. Subsequent analysis identified a 107-bp beta-MHC promoter sequence (-303/-197) sufficient to convert a heterologous neutral promoter to one that is activated by aortic constriction. These sequences contain two M-CAT elements, which have previously been demonstrated to mediate inducible expression during alpha1-adrenergic-stimulated hypertrophy in cultured neonatal cardiac myocytes, and a GATA element. Although simultaneous mutation of both M-CAT elements markedly decreased the basal transcriptional activity of an injected 333-bp beta-MHC promoter, it had no effect on aortic constriction-stimulated transcription (3.5-fold increase, P<.005 for both wild type and mutant). In contrast, mutation of the GATA motif markedly attenuated aortic constriction-stimulated transcription (1.6-fold, P=NS) without affecting the basal transcriptional activity. This GATA site can interact with in vitro translated GATA-4 and compete with an established GATA site for GATA-4 binding activity in nuclear extracts from aortic constricted hearts. CONCLUSIONS Basal and aortic constriction-stimulated transcription of the beta-MHC gene is mediated, at least in part, through different mechanisms. A GATA element within beta-MHC sequences -303/-197 plays a role in the transcriptional activation of this gene by aortic constriction.

[1]  M. L. Kaplan,et al.  Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. , 1993, Circulation research.

[2]  I. Klein,et al.  Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Karns,et al.  An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1-adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. , 1994, The Journal of biological chemistry.

[4]  I. Pastan,et al.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Chien,et al.  Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  A. Ardati,et al.  A nuclear pathway for alpha 1‐adrenergic receptor signaling in cardiac cells. , 1993, The EMBO journal.

[7]  K. Chien,et al.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.

[8]  K. Chien,et al.  Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. , 1991, The Journal of biological chemistry.

[9]  B. Nadal-Ginard,et al.  A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. , 1991, The Journal of biological chemistry.

[10]  M. Nemer,et al.  A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription , 1994, Molecular and cellular biology.

[11]  K Sigrist,et al.  GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. , 1997, Genes & development.

[12]  K. M. Gianola,et al.  Complete nucleotide sequence of full length cDNA for rat α cardiac myosin hea chain , 1989 .

[13]  J. Seidman,et al.  Cis-acting sequences that modulate atrial natriuretic factor gene expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Farrance,et al.  M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1. , 1992, The Journal of biological chemistry.

[15]  P. Simpson,et al.  Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter. , 1993, The Journal of biological chemistry.

[16]  R. Matsuoka,et al.  Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. , 1987, The Journal of clinical investigation.

[17]  C. Long,et al.  Alpha 1-adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. , 1989, The Journal of clinical investigation.

[18]  R. Zak,et al.  cis-acting elements responsible for muscle-specific expression of the myosin heavy chain beta gene. , 1992, Nucleic acids research.

[19]  N. Rosenthal,et al.  Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus , 1996, Molecular and cellular biology.

[20]  H. Rindt,et al.  In vivo analysis of the murine beta-myosin heavy chain gene promoter. , 1993, The Journal of biological chemistry.

[21]  C. Chassagne,et al.  Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. , 1993, Circulation research.

[22]  J. Edwards,et al.  Characterization of a strong positive cis-acting element of the human beta-myosin heavy chain gene in fetal rat heart cells. , 1992, The Journal of biological chemistry.

[23]  D. Wilson,et al.  The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells , 1994, Molecular and cellular biology.

[24]  S. Izumo,et al.  Both a ubiquitous factor mTEF-1 and a distinct muscle-specific factor bind to the M-CAT motif of the myosin heavy chain beta gene. , 1993, Nucleic acids research.

[25]  J. Seidman,et al.  The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. , 1984, Science.

[26]  E. Olson,et al.  Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. , 1997, Genes & development.

[27]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[28]  L. Leinwand,et al.  Hormonal modulation of a gene injected into rat heart in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Molkentin,et al.  Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Leinwand,et al.  Gene transfer into adult rat heart in vivo. , 1993 .

[31]  K. Boheler,et al.  Switches in cardiac muscle gene expression as a result of pressure and volume overload. , 1992, The American journal of physiology.

[32]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Karns,et al.  M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. , 1995, The Journal of biological chemistry.

[34]  K. Chien,et al.  A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alpha-adrenergic-inducible expression in cultured neonatal rat myocardial cells , 1991, Molecular and cellular biology.

[35]  J. Molkentin,et al.  An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo , 1994, Molecular and cellular biology.

[36]  J. Sadoshima,et al.  Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. , 1992, The Journal of biological chemistry.

[37]  Geraedts Jp.  Methods in molecular genetics , 1987 .

[38]  L. Chin,et al.  Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1. , 1994, Oncogene.

[39]  R. Lefkowitz,et al.  Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Aoyagi,et al.  Mapping of the pressure response element of the c-fos gene by direct DNA injection into beating hearts. , 1993, The Journal of biological chemistry.

[41]  S. Bolling,et al.  Expression of recombinant genes in myocardium in vivo after direct injection of DNA. , 1990, Circulation.

[42]  M. Pfeffer,et al.  Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. , 1988, The Journal of clinical investigation.

[43]  T. Evans,et al.  Regulation of Cardiac Gene Expression by GATA-4/5/6. , 1997, Trends in cardiovascular medicine.

[44]  B. Nadal-Ginard,et al.  Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. , 1989, The Journal of clinical investigation.

[45]  I. Klein,et al.  In vivo regulation of recombinant cardiac myosin heavy chain gene expression by thyroid hormone. , 1993, Endocrinology.

[46]  S. Schiaffino,et al.  Nonsynchronous Accumulation of α‐Skeletal Actin and β‐Myosin Heavy Chain mRNAs During Early Stages of Pressure‐Overload‐Induced Cardiac Hypertrophy Demonstrated by In Situ Hybridization , 1989, Circulation research.

[47]  J. Mar,et al.  Characterization of a promoter element required for transcription in myocardial cells. , 1991, The Journal of biological chemistry.

[48]  J. Molkentin,et al.  Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene , 1994, Molecular and cellular biology.

[49]  K. Boheler,et al.  Cardiac expressions of alpha- and beta-myosin heavy chains and sarcomeric alpha-actins are regulated through transcriptional mechanisms. Results from nuclear run-on assays in isolated rat cardiac nuclei. , 1992, The Journal of biological chemistry.

[50]  C. Ordahl.  Developmental regulation of sarcomeric gene expression. , 1992, Current topics in developmental biology.

[51]  A. Brasier,et al.  Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.

[52]  W. Rutter,et al.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. , 1985, Science.

[53]  C. Seidman,et al.  Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. , 1995, The Journal of clinical investigation.

[54]  S. Nordeen,et al.  Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.

[55]  H. Rindt,et al.  In vivo regulation of the mouse beta myosin heavy chain gene. , 1994, The Journal of biological chemistry.

[56]  L. Leinwand,et al.  Discordance between gene regulation in vitro and in vivo. , 1992, Gene expression.

[57]  T. Lee,et al.  Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. , 1994, The Journal of biological chemistry.

[58]  M. L. Kaplan,et al.  Behavior of genes directly injected into the rat heart in vivo. , 1992, Circulation research.